Department of Neurology, St. Josef - Hospital, Ruhr-University
Bochum, North Rhine-Westphalia, D-44791, Germany
Completed
NCT Number: NCT01273935
Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
The aim of this study is to evaluate the low-response prevalence of early antiplatelet therapy and to test the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
Antiplatelet agents are important therapeutic options in treating patients with acute ischemic strokes to prevent recurrent ischemic events or death. The aim of this study was to evaluate the low-response prevalence of early antiplatelet therapy and the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- suspected acute cerebrovascular ischemic events and patients who were admitted to the stroke unit where antiplatelet therapy was initiated
Exclusion criteria
- severe liver disorders, current gastrointestinal disorders, congestive heart failure, life-threatening malignancies and a personal or family history of bleeding disorders
Treatment and study plan
Primary outcomes
-
Result of platelet function test
Aggregometry result of antiplatelet therapy
Sponsors and collaborators
Lead sponsor
Ruhr University of Bochum
Other
Registry information
Important dates
- Study start
- 2010
- Study completion
- 2010
- First posted
- Jan 11, 2011
- Registry last updated
- Jan 11, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.